CN108057020A - A kind of pyridaben antiparasitic preparation for animals and preparation method thereof - Google Patents

A kind of pyridaben antiparasitic preparation for animals and preparation method thereof Download PDF

Info

Publication number
CN108057020A
CN108057020A CN201711129833.8A CN201711129833A CN108057020A CN 108057020 A CN108057020 A CN 108057020A CN 201711129833 A CN201711129833 A CN 201711129833A CN 108057020 A CN108057020 A CN 108057020A
Authority
CN
China
Prior art keywords
pyridaben
preparation
antiparasitic
animals
double solvents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711129833.8A
Other languages
Chinese (zh)
Inventor
刘肖娟
谭志坚
黎剑坤
翁亚彪
符德文
袁增辉
陈艺青
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FOSHAN ZHENGDIAN BIOTECHNOLOGY Co Ltd
Foshan Standard Bio Tech Co Ltd
Original Assignee
FOSHAN ZHENGDIAN BIOTECHNOLOGY Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by FOSHAN ZHENGDIAN BIOTECHNOLOGY Co Ltd filed Critical FOSHAN ZHENGDIAN BIOTECHNOLOGY Co Ltd
Priority to CN201711129833.8A priority Critical patent/CN108057020A/en
Publication of CN108057020A publication Critical patent/CN108057020A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a kind of pyridaben antiparasitic preparations for animals and preparation method thereof, belong to field of veterinary.The pyridaben antiparasitic preparation for animals includes pyridaben 1~30%, double solvents 5~60%, emulsifier 5~30%, infiltration synergist 1~25%, and surplus is diluent;The double solvents is made of glycerol formal, propylene glycol, dimethyl acetamide and purified water.Pharmaceutical grade and food grade solvent used in pyridaben antiparasitic preparation for animals provided by the present invention are the substance of hypotoxicity, solves the solubility problem of pyridaben by compounding perfection, the defects of solvent toxicity used in existing pyridaben preparation can be overcome larger, animal health may be endangered.Product of the present invention is directly can to pour into a mould or embrocate in the pyridaben preparation on livestock and poultry fur, its active ingredient is made to achieve the effect that kill vermin by fur diffusion, is had no toxic side effect and drug residues, safe to use, economical environment-protective.

Description

A kind of pyridaben antiparasitic preparation for animals and preparation method thereof
Technical field
The invention belongs to field of veterinary, and in particular to a kind of pyridaben antiparasitic preparation for animals and preparation method thereof.
Background technology
Pyridaben chemical name is the chloro- 2H- pyridazin-3-ones of 2- tertiary butyls -5- (4- tertiary butyls benzylthio) -4-, is colourless Crystal belongs to pyridazinone Insecticidal and acaricidal agent, without interior absorption.Pyridaben is less toxic contact acaricide, to tetranychid, Panonychus citri, Unguiculus mite closes the food vegetalitas evil mite such as goitre mite and is respectively provided with apparent control effect, and to ovum, deutonymph, effective into mite, into mite The mobile phase it is also effective.According to Wang Jianguo et al.《Metrifonate, pyridaben observe the effect of pig's sarcoptidosis》(Wang Jianguo, Zhang Xianhui The effect of metrifonate, pyridaben is to pig's sarcoptidosis observation [J] Henan animal and veterinary:General news column, 2000 (11):25-25.) report Pyridaben is heterocyclic compound insecticides, cures mainly red spider, and itch mite and red spider are insect of the same race, therefore pyridaben is to itch mite Worm also shows good killing effect.Experiments have shown that pyridaben has apparent effect for the scabies mite prevention of poultry, there is height The advantages that effect is less toxic, cheap, easy to use.
Since pyridaben itself is not soluble in water, the dissolubility in each solvent is poor, "《Newly organized pesticide commodity handbook》 In the pyridaben physics and chemistry that (Zhang Minheng is edited, Chemical Industry Press, 2006.6) includes, and pyridaben dissolubility (20 DEG C, g/ L):Ketone 0.46, benzene 110, dimethylbenzene 390, ethyl alcohol 57, thiacyclohexane 320, n-octyl alcohol 63, normal hexane 10.“《Chinese pharmaceutic adjuvant》” It is mentioned in (Luo Mingsheng, Gao Tianhui, Beijing, Chemical Industry Press, 2006):Solvent is by toxicity magnitude classification one kind, two classes, three Class, four class solvents.A kind of toxicity is big, such as benzene, carbon tetrachloride etc., generally forbids to use, and two classes use for limitation, three classes hypotoxicity Solvent, four classes are without enough toxicity data solvents.
Traditional pyridaben product goes to make usually using substantial amounts of organic solvent.As contained in pyridaben missible oil product The organic solvents such as a large amount of dimethylbenzene, toluene.This kind of organic solvent smell and toxicity are all very big.At present, rattled away due to commercially available Related product such as emulsion of mite spirit etc. is not the veterinary drug developed for animal, has been used in preparation substantial amounts of organic molten Agent, these organic solvent toxicities are deeper, larger to the side effect of poultry, may cause the inadaptable of animal, can additionally pollute Environment and water source." a kind of active ingredient is the aqueous emulsion of pyridaben to the Chinese patent that number of patent application is 200810101134.7 And preparation method thereof " and number of patent application be a kind of 200810101922.6 Chinese patents " preparation side of pyridaben micro-emulsion Method ", they are primarily directed to crops and plant uses, solvent (dimethylbenzene, toluene, dimethylformamide etc.) and emulsification Agent (33#, 34# etc.) is mostly the big preparation of toxicity, is not suitable for animal use.In addition, with regard to pyridaben dissolubility wherein and Speech, only dimethylbenzene or thiacyclohexane dissolubility is larger, and suitable for the solvent of pyridaben, and dimethylbenzene and thiacyclohexane are all toxicity Greatly, the big solvent of smell is not suitable for livestock and poultry use.
Therefore, a kind of pyridaben antiparasitic preparation for animals efficiently, less toxic is developed to be of great significance.
The content of the invention
It is an object of the invention to overcome the deficiencies of the prior art and provide a kind of pyridabens for animals efficiently, less toxic, environmentally friendly Antiparasitic preparation and preparation method thereof.
The technical solution used in the present invention is:
A kind of pyridaben antiparasitic preparation for animals includes the component of following masses percentage:Pyridaben 1~30% is answered Bonding solvent 5~60%, emulsifier 5~30%, infiltration synergist 1~25%, surplus is diluent;The double solvents is by sweet Oily formal, propylene glycol, dimethyl acetamide and purified water composition.
Preferably, the double solvents includes the component of following masses percentage:Glycerol formal 1-45%, propylene glycol 2- 30%th, dimethyl acetamide 5-75%, surplus are purified water.
Preferably, the double solvents includes the component of following masses percentage:Glycerol formal 15-30%, propylene glycol 2-10%, dimethyl acetamide 45-65%, surplus are purified water.
Preferably, the double solvents includes the component of following masses percentage:Glycerol formal 25%, propylene glycol 5%, Dimethyl acetamide 55%, surplus purified water.
The present invention is compounded to obtain double solvents using glycerol formal, propylene glycol, dimethyl acetamide, purified water, It can be very good to solve the problems, such as that pyridaben dissolubility is bad.Solubility of the pyridaben in double solvents is about 332g/L.This Outside, it is nonirritant since each component in double solvents has small toxicity, the features such as the stink of no discomfort, (dissolved with dimethylbenzene Spend for 390g/L), thiacyclohexane (solubility is about 320g/L) compare, be more suitable for solvent.
Preferably, it is (8- that infiltration synergist, which is long chain glyceride or medium chain triglycerides and water-based azone according to mass ratio, 12):(4-7) is mixed to get.
Preferably, medium chain triglycerides are MCT Oil.
Long chain glyceride and medium chain triglycerides viscosity are low, and solidification point is low, can make the moisturizing factor and antifreezing agent of transdermal solution. Long chain glyceride and medium chain triglycerides liquid condition are very intact, have good antioxygenic property, prevent oxidation of drug, improve The quality of transdermal solution and storage period.While long chain glyceride and medium chain triglycerides are absorbed by the skin, drug is also corresponding Ground absorbs therewith.
The present invention is combined using long chain glyceride and medium chain triglycerides with high-effective penetrating promoter azone, increases skin keratin The flowing of layer lipoid, so as to increase penetrability of the drug to skin, gets through skin barrier, plays the role of playing drug effect.
Preferably, emulsifier is Tween 80, polysorbate60, polysorbas20, sorbester p18, sorbester p17, sorbester p37, hydrogenation polyoxyethylene One kind or any number of combination in castor oil, Emulsifier EL-60.
Preferably, diluent is purified water.
A kind of preparation method of pyridaben antiparasitic preparation for animals, according to each component is weighed described in any of the above-described, first Double solvents is heated to 40-50 DEG C, adds in pyridaben, stirring and dissolving;Emulsifier is added, 1800-2200r/ minutes at a high speed It is mixed into O/W states;It adds infiltration synergist to stir evenly, adds diluent to full dose, pyridaben for animals is prepared kills and post Infested preparation.
The beneficial effects of the invention are as follows:
The present invention provides a kind of pyridaben antiparasitic preparation for animals, which is colourless to yellow clarified solution body, color and luster Uniformly, property is stablized.
Pharmaceutical grade and food grade solvent used in pyridaben antiparasitic preparation for animals provided by the present invention are hypotoxicity Substance, solve the solubility problem of pyridaben by compounding perfection, can overcome molten used in existing pyridaben preparation Agent toxicity is larger, the defects of may endangering animal health.
The characteristics of present invention easily multiplies for livestock and poultry fur and carries parasite, providing one kind directly can pour into a mould or embrocate In the pyridaben preparation on livestock and poultry fur, its active ingredient is made to achieve the effect that kill vermin by fur diffusion, this Product have no toxic side effect and drug residues.
The homogeneous stability system that the present invention is formed using water as matrix, by dissolving the processes such as active compound, microemulsified, surface are lived Property agent content it is high, emulsified particles is small, and drug effect is high using effect.The present invention reduces cost by matrix of water, mitigates pollution pressure.
Present invention pyridaben preparation for animals is efficient, it is less toxic, safe to use, energy saving, do not pollute substantially.
Preparation method provided by the present invention is simple to operation, is easy to implement industrialization.
Specific embodiment
In order to further deepen explanation of the invention and realize present invention convenient for masses, below in conjunction with specific reality Applying example and comparative example, the present invention will be further described.
Embodiment 1
10% pyridaben antiparasitic preparation includes the component of following masses percentage:
Wherein double solvents is by glycerol formal 25%, propylene glycol 5%, dimethyl acetamide 55%, surplus purified water group Into by mass percentage.
Permeating synergist is:MCT Oil and water-based azone are according to mass ratio 10:5 are mixed to get.
Preparation method:Accurate to weigh pyridaben original powder, pyridaben is dissolved as liquid by the double solvents for adding in warm (45 DEG C) After body shape object, add Tween 80 and be sufficiently stirred emulsification, then mixed at high speed (2000r/ minutes) adds in infiltration into O/W states Synergist stirs evenly, and last surplus adds in purified water, and stirs evenly to get 10% pyridaben antiparasitic preparation.
By detection, pyridaben is about 332g/L in double solvents solubility in the present embodiment.
Embodiment 2
15% pyridaben microemulsion formulation, including following masses percent composition:
Wherein double solvents is by glycerol formal 25%, propylene glycol 5%, dimethyl acetamide 55%, surplus purified water group Into by mass percentage.
Permeating synergist is:MCT Oil and water-based azone are according to mass ratio 10:5 are mixed to get.
Preparation method:Accurate to weigh pyridaben original powder, pyridaben is dissolved as liquid by the double solvents for adding in warm (45 DEG C) After body shape object, add Tween 80 and be sufficiently stirred emulsification, then mixed at high speed (2000r/ minutes) adds in infiltration into O/W states Synergist stirs evenly, and last surplus adds in purified water, and stirs evenly to get 15% pyridaben antiparasitic preparation.
By detection, pyridaben is about 333g/L in double solvents solubility in the present embodiment.
Embodiment 3
10% pyridaben antiparasitic preparation, including following masses percent composition:
Wherein double solvents is by glycerol formal 25%, propylene glycol 5%, dimethyl acetamide 55%, surplus purified water group Into;By mass percentage.
Permeating synergist is:MCT Oil and water-based azone are according to mass ratio 10:5 are mixed to get.
Preparation method:Accurate to weigh pyridaben original powder, pyridaben is dissolved as liquid by the double solvents for adding in warm (45 DEG C) After body shape object, add Tween 80 and be sufficiently stirred emulsification, then mixed at high speed (2000r/ minutes) adds in infiltration into O/W states Synergist stirs evenly, and last surplus adds in purified water, and stirs evenly to get 10% pyridaben antiparasitic preparation.
By detection, pyridaben is about 331g/L in double solvents solubility in the present embodiment.
Embodiment 4
15% pyridaben microemulsion formulation, including following masses percent composition:
Wherein double solvents is by glycerol formal 25%, propylene glycol 5%, dimethyl acetamide 55%, surplus purified water group Into;By mass percentage.
Permeating synergist is:MCT Oil and water-based azone are according to mass ratio 10:5 are mixed to get.
Preparation method:Accurate to weigh pyridaben original powder, pyridaben is dissolved as liquid by the double solvents for adding in warm (45 DEG C) After body shape object, add Tween 80 and be sufficiently stirred emulsification, then mixed at high speed (2000r/ minutes) adds in infiltration into O/W states Synergist stirs evenly, and last surplus adds in purified water, and stirs evenly to get 15% pyridaben microemulsion formulation.
By detection, pyridaben is about 332g/L in double solvents solubility in the present embodiment.
Related assays are carried out to the product of embodiment.
Detection project and requirement are as follows:
(1) transparency temperature scope:-5℃-65℃.
(2) through when stablize:It is stored under room temperature 60 days and stablizes qualification.
(3) low-temperature stabilization:- 5 DEG C storage 14 days it is not stratified, not muddy, do not crystallize.
(4) heat storage stability:It is stored 2 weeks under conditions of 55 ± 2 DEG C, detects the content of active ingredient, calculate content point Solution rate, no more than 5%;Observation occurs without oil reservoir and precipitation.
(5) stability of emulsion (20 times):200 times are diluted with standard hard water, 1h is stood in 30 DEG C of waters bath with thermostatic control and is taken out, is seen Examine lotion separation situation or on without under oil slick without precipitation.
By measuring, the product indices of embodiment 1-4 are qualified.
In order to absolutely prove beneficial effects of the present invention, beneficial effects of the present invention are done further below by way of test example Explanation.
Test example one:Pyridaben antiparasitic preparation stability tests (accelerated test)
1st, test objective:Prove that pyridaben antiparasitic preparation nature provided by the present invention is stablized, content is maintained at mark It is more than quasi- value.
2nd, trial drug:10% pyridaben antiparasitic preparation, prepares, lot number 16102101 according to embodiment 1.15% Pyridaben antiparasitic preparation, prepares according to embodiment 2, lot number 16102102.More than sample is by the positive allusion quotation biology in Foshan City Technology Co., Ltd. provides.
3rd, test method:Reference《Republic of China Veterinary Pharmacopoeia》Accelerated test in one stability of version in 2015 is surveyed The method of determining is detected.By commercially available back, in 40 DEG C ± 2 DEG C of temperature, placed 6 months under conditions of relative temperature 70% ± 5%, it is real When monitor humiture, 1st month during experiment, 2 months, 3 months, 6 the end of month it is separately sampled once, detection wherein pyridaben Content.
4th, result of the test is shown in Table 1.
1 pyridaben stability test result of table
1 result of table the result shows that, a kind of pyridaben antiparasitic preparation for animals of the invention pass through accelerated test, content Change less, property stabilization.
Test example two, the experiment of pyridaben antiparasitic preparation mite killing safe effect
1st, test objective:It is low toxicity, the mite-killing preparation of safety to prove pyridaben antiparasitic preparation provided by the present invention.
2nd, trial drug:10% pyridaben antiparasitic preparation, prepares, lot number 16102101 according to embodiment 1.15% Pyridaben antiparasitic preparation, prepares according to embodiment 2, lot number 16102102.More than sample is by the positive allusion quotation biology in Foshan City Technology Co., Ltd. provides.
3rd, test method:30 chickens are selected, are randomly divided into 3 groups, every group 10.Respectively 10% pyridaben group, 15% Pyridaben group and blank control group.10% and 15% pyridaben antiparasitic preparation is taken to embrocate under each group chicken wing respectively On square soft textive, observe whether its mental condition and skin have red and swollen appearance.And it is compared with not applying any acaricidal blank.
4th, result of the test is shown in Table 2.
2 pyridaben miticidal effect of table is tested
Table 2 the result shows that, a kind of pyridaben antiparasitic preparation for animals of the invention is directly embrocated on chicken, spirit it is good Good, chicken is a kind of safe and efficient mite-killing preparation without red swelling of the skin, damage and inflammation phenomenon.
Test example three, the experiment of pyridaben antiparasitic preparation miticidal effect
1st, test objective:It is efficient mite-killing preparation to prove pyridaben antiparasitic preparation provided by the present invention.
2nd, trial drug:
10% pyridaben antiparasitic preparation, prepares, lot number 16102101 according to embodiment 1.
Control group 1:Preparation method is same as Example 1, does not add infiltration synergist in formula.
Control group 2:Purified water blank group compares.
More than sample is provided by Zhengdian Biological Tech. Co., Ltd., Foshan City.
3rd, test method:The affected pig of farm natural infection itch mite 30 is randomly divided into 3 groups, every group 10.Take each group sample Product are according to 1:300 dosage spray is shone in the pig of corresponding group, and 3 days are once, are used in conjunction 2 times, observe its mental condition and in 7 days, Its except mite effect is visually observed after 14 days.And it is compared with purified water blank group.
4th, result of the test is shown in Table 3.
3 pyridaben miticidal effect of table is tested
Table 3 the result shows that, a kind of apparent, the of the invention pyridaben antiparasitic for animals of addition infiltration synergist synergistic effect Preparation has display effect to pig's sarcoptidosis, is a kind of less toxic, efficient mite-killing preparation.
Comparative example 1
It is formulated with embodiment 1, the difference is that, double solvents is pure by glycerol formal 40%, propylene glycol 30%, surplus Change water composition.
By detection, pyridaben is about 25g/L in double solvents solubility in this comparative example.Due to the solubility of pyridaben It is bad, obtain that product is unstable in room temperature storage and when low-temp storage, and easily muddy, crystallization is undesirable.
Comparative example 2
It is formulated with embodiment 1, the difference is that, double solvents is by propylene glycol 20%, dimethyl acetamide 55%, surplus Purified water forms.
By detection, pyridaben is about 88g/L in double solvents solubility in this comparative example.Due to the solubility of pyridaben It is bad, obtain that product is unstable in room temperature storage and when low-temp storage, and easily muddy, crystallization is undesirable.
Comparative example 3
Formula with embodiment 1, the difference is that, double solvents by glycerol formal 25%, dimethyl acetamide 55%, Surplus purified water forms.
By detection, pyridaben is about 106g/L in double solvents solubility in this comparative example.Due to the dissolving of pyridaben It spends bad, obtains that product is unstable in room temperature storage and when low-temp storage, and easily muddy, crystallization is undesirable.
Comparative example 4
It is formulated with embodiment 1, the difference is that, double solvents is by glycerol formal 20%, propylene glycol 35%, dimethyl Acetamide 20%, surplus purified water composition.
The usage amount of propylene glycol is excessive in this comparative example, overruns, and the dosage of corresponding dimethyl acetamide is reduced, Obtained double solvents is not good enough for the solute effect of pyridaben.By detection, pyridaben is dissolved in double solvents in this comparative example Degree is about 78g/L.Since the solubility of pyridaben is bad, product unstable, appearance in room temperature storage and low-temp storage is obtained Easily muddy, crystallization, it is undesirable.
Above-described embodiment is the preferable embodiment of the present invention, but embodiments of the present invention and from above-described embodiment Limitation, other any Spirit Essences without departing from the present invention with made under principle change, modification, replacement, combine, simplification, Equivalent substitute mode is should be, is included within protection scope of the present invention.

Claims (7)

1. a kind of pyridaben antiparasitic preparation for animals, which is characterized in that include the component of following masses percentage:Pyridaben 1 ~30%, double solvents 5~60%, emulsifier 5~30%, infiltration synergist 1~25%, surplus is diluent;It is described compound Solvent is made of glycerol formal, propylene glycol, dimethyl acetamide and purified water.
2. pyridaben antiparasitic preparation for animals according to claim 1, which is characterized in that under the double solvents includes The component of row mass percent:Glycerol formal 1-45%, propylene glycol 2-30%, dimethyl acetamide 5-75%, surplus are pure Change water.
3. pyridaben antiparasitic preparation for animals according to claim 2, which is characterized in that under the double solvents includes The component of row mass percent:Glycerol formal 15-30%, propylene glycol 2-10%, dimethyl acetamide 45-65%, surplus are Purified water.
4. pyridaben antiparasitic preparation for animals according to claim 1, it is characterised in that:It is sweet for long-chain to permeate synergist Grease or medium chain triglycerides and water-based azone are (8-12) according to mass ratio:(4-7) is mixed to get.
5. pyridaben antiparasitic preparation for animals according to claim 1, it is characterised in that:Emulsifier is Tween 80, spits Temperature 60, polysorbas20, sorbester p18, sorbester p17, sorbester p37, hydrogenation Emulsifier EL-60, one kind in Emulsifier EL-60 or Any number of combination.
6. pyridaben antiparasitic preparation for animals according to claim 1, it is characterised in that:Diluent is purified water.
7. a kind of preparation method of pyridaben antiparasitic preparation for animals, it is characterised in that:According to any one of claim 1-6 institutes It states and weighs each component, double solvents is first heated to 40-50 DEG C, add in pyridaben, stirring and dissolving;Add emulsifier, 1800- 2200r/ minutes mixed at high speed are into O/W states;It adds infiltration synergist to stir evenly, diluent is added to be prepared to full dose Pyridaben antiparasitic preparation for animals.
CN201711129833.8A 2017-11-15 2017-11-15 A kind of pyridaben antiparasitic preparation for animals and preparation method thereof Pending CN108057020A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711129833.8A CN108057020A (en) 2017-11-15 2017-11-15 A kind of pyridaben antiparasitic preparation for animals and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711129833.8A CN108057020A (en) 2017-11-15 2017-11-15 A kind of pyridaben antiparasitic preparation for animals and preparation method thereof

Publications (1)

Publication Number Publication Date
CN108057020A true CN108057020A (en) 2018-05-22

Family

ID=62134900

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711129833.8A Pending CN108057020A (en) 2017-11-15 2017-11-15 A kind of pyridaben antiparasitic preparation for animals and preparation method thereof

Country Status (1)

Country Link
CN (1) CN108057020A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114306231A (en) * 2021-12-29 2022-04-12 天津市中升挑战生物科技有限公司 Flurara pesticide and preparation method and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101530074A (en) * 2008-03-14 2009-09-16 北京绿色农华植保科技有限责任公司 Preparation method of pyridaben micro-emulsion
CN102603669A (en) * 2012-04-05 2012-07-25 南开大学 Derivatives of alpha-methoxyl imino-5-methyl-1,2,3-thiadiazole-4- carboxylic acid methyl ester and preparation methods and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101530074A (en) * 2008-03-14 2009-09-16 北京绿色农华植保科技有限责任公司 Preparation method of pyridaben micro-emulsion
CN102603669A (en) * 2012-04-05 2012-07-25 南开大学 Derivatives of alpha-methoxyl imino-5-methyl-1,2,3-thiadiazole-4- carboxylic acid methyl ester and preparation methods and uses thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
刘宗达: "《农药安全使用手册》", 30 September 2009, 上海科学技术出版社 *
张超云,等: "《药剂学》", 30 November 2013, 辽宁大学出版社 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114306231A (en) * 2021-12-29 2022-04-12 天津市中升挑战生物科技有限公司 Flurara pesticide and preparation method and application thereof

Similar Documents

Publication Publication Date Title
DE69929313T2 (en) METHOD AND COMPOSITIONS FOR THE ADMINISTRATION OF TAXANES
WO2021093271A1 (en) Beta cypermethrin nano aqueous agent, preparation method therefor and use thereof
WO2021068270A1 (en) Nano aqueous formulation comprising chlorpyrifos and preparation method thereof
CN101548679B (en) Matrine type alkaloid microemulsion and preparation method thereof
US20230172208A1 (en) Preparation Method of Eucalyptol Emulsion and Application Thereof in Biopesticides
TWI236376B (en) Topical organic ectoparasiticidal compositions
CN104488998A (en) Synergistic compound hicide caphidicide containing sophocarpidine and preparation method of synergistic compound hicide caphidicide
CN102239890B (en) Microcapsule suspension used for preventing and controlling spiraling whitefly and preparation method thereof
CN102988376B (en) Fishery medicine of eucalyptus oil abamectin sub-microemulsion
CN108057020A (en) A kind of pyridaben antiparasitic preparation for animals and preparation method thereof
CN101843268B (en) Botanical synergistic compound aphicide and preparation method thereof
CN105030760A (en) Stable pharmaceutical composition
CN107637597A (en) A kind of jinggangmycin solid solution and preparation method thereof
CN109833296A (en) Can the new merit chigger disease of prevention and control plants essential oil microemulsion formulation and preparation method thereof
CN114588108B (en) Oil-soluble solution containing insect repellent and preparation method and application thereof
CN103734153B (en) A kind of water-soluble biological insecticide containing active Avermectin and preparation method thereof
CN105145619A (en) Pyrethroid pesticide aqueous emulsion and preparation method thereof
CN107593696A (en) Clodinafop-propargyl missible oil of high-efficiency environment friendly and its preparation method and application
CN107736356A (en) A kind of municipal gardens trees insecticide and preparation method thereof, application method
CN106342796A (en) Application technology of paclobutrazol in insecticidal water emulsion
Kumar Anticandidal activity of ethosomal gel containing miconazole nitrate in male Sprague Dawley rat
CN101611708A (en) A kind of rotenone micro-emulsion
CN114600899B (en) Preparation method and application of pyraclostrobin and propiconazole microemulsion
EP2142169A2 (en) Aqueous pharmaceutical preparation
CN109197891A (en) Kill bedbug medicament and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20180522